publication date: Aug. 1, 2014

html PCORI.html

By Will Craft and Matthew Ong

The Patient-Centered Outcomes Research Institute approved $54.8 million for 33 clinical effectiveness projects.

The projects, approved by the institute’s board of governors July 29, will study ways to improve outcomes for patients with cancer and other diseases, including diabetes, nervous system disorders, cardiovascular diseases, mental health conditions and kidney diseases.

The studies will compare different approaches to delivering care, improving patient access, and patient-centered clinical effectiveness research methods. Several projects will focus on particular populations, including older adults, minorities, children and low-income individuals.

Selected from 325 applications from funding announcements issued in September 2013, the approved studies are based at institutions and organizations across 18 states. All awards were approved after a business programmatic review by PCORI staff and issuance of a formal award contract, the institute said.

PCORI is refining their funding announcements to focus on priority topics and larger, pragmatic studies, said the institute’s executive director, Joe Selby.

Since it began funding research in 2012, PCORI has approved nearly $549 million in support of 313 research projects and initiatives. The institute said it expects to award about $1 billion in research support by the end of next year.

Nina Bickell, professor of medicine and population health science and policy at Mount Sinai School of Medicine, proposed a three-year, $2 million project to study and improve patient care for late-stage cancer.

Among advanced cancer patients, discussions about prognosis, goals of care, and end-of-life preferences improve patients’ quality of life and reduce hospital and ICU admission rates,” the project … Continue reading 40-31 PCORI Approves $54.8 Million For Clinical Effectiveness Research

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.